Exelon Corporation (EXC) witnesses a surge in trading activities, with individual entities such as
Measured Wealth Private Client Group LLC,
Prudential Financial Inc., and
Morgan Stanley taking significant positions. This underlines its broad appeal among institutional investors who hold approximately 87% of the company. These investors include
Legal & General Group Plc,
Vanguard Group Inc., and
Massachusetts Financial Services Co, to name a few. Calculating the fair value of EXC has become a focal point, impacting its price target and long-term forecast. Corporately, Exelon is engaged in a series of activities, like a preliminary approval for
derivative action settlement, a temporary trading suspension, and forthcoming executive changes. The company boasts strong financial results with its Q3 results exceeding estimates and a forecasted ROE of approximately 10%. A considerable boost in operating capacity and reaffirmed 2025 guidance indicate robust growth. Despite increasing momentum, its stock sold off in certain cases, but it still offers a fruitful opportunity for investors, having delivered a 107% gain over five years.
Exelon Corporation EXC News Analytics from Tue, 13 May 2025 07:00:00 GMT to Sat, 29 Nov 2025 13:13:45 GMT -
Rating 7
- Innovation 5
- Information 8
- Rumor -3
